MACQUARIE GROUP LTD - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
MACQUARIE GROUP LTD ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$24,000
+20.0%
0
-100.0%
0.00%
Q2 2022$20,000
-31.0%
5100.0%0.00%
Q1 2022$29,000
-29.3%
5100.0%0.00%
Q4 2021$41,000
+86.4%
510
+105.6%
0.00%
Q3 2021$22,000
-31.2%
2480.0%0.00%
Q2 2021$32,000
+60.0%
2480.0%0.00%
Q1 2021$20,000
-33.3%
248
-32.1%
0.00%
Q4 2020$30,000
+233.3%
3650.0%0.00%
Q3 2020$9,000
-10.0%
3650.0%0.00%
Q2 2020$10,0003650.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$205,573,00024.93%
HSG Holding Ltd 796,089$69,268,0006.22%
DC Investments Management, LLC 21,010$1,828,0003.41%
Redmile Group, LLC 1,975,006$171,845,0003.00%
Casdin Capital, LLC 818,820$71,246,0001.77%
Evolutionary Tree Capital Management, LLC 44,390$3,862,0001.71%
HHLR ADVISORS, LTD. 1,448,161$126,004,0001.65%
Nan Fung Group Holdings Ltd 54,903$4,777,0001.53%
ARK Investment Management 6,841,722$595,298,0001.43%
BRANDYWINE MANAGERS, LLC 12,900$1,122,0001.17%
View complete list of BEAM THERAPEUTICS INC shareholders